Referred to the House Committee on Energy and Commerce.
Health
Why This Matters
This bill aims to speed up research on new brain tumor treatments and improve public awareness and access to specialized cancer and brain tumor care.
Who this affects
NIH-funded researchers · medical institutions · health care providers · patients with brain tumors
What changes is this bill making?
1Requires organizations that collect NIH (National Institutes of Health)–funded brain tumor specimens to report them to a public, searchable website within set timeframes
2Creates a Glioblastoma Therapeutics Network with $50 million annually from fiscal years 2026 to 2030 to support early-stage treatment trials for glioblastoma
3Establishes $10 million per year from 2026 through 2030 for multi-institutional awards to develop and test brain tumor cellular immunotherapies, including chimeric antigen receptor-T (CAR-T)
4Directs a national campaign to raise awareness among patients, caregivers, and health care providers about cancer clinical trials and biomarker testing, with materials tailored to high-risk, rural, and diverse communities
5Funds demonstration projects to compare outreach and education methods on clinical trials and biomarker testing for brain tumor patients, families, and health professionals
6Authorizes $5 million annually from 2026 to 2030 for pilot programs to develop and evaluate lifelong monitoring and care models for adult and pediatric brain tumor survivors
7Requires the Food and Drug Administration to issue guidance within one year to reduce the exclusion of brain tumor patients and those with rare cancers from clinical trials of other treatments
